超声检测胎盘植入谱系疾病的孕期特异性诊断准确性:系统综述与Meta分析
该系统综述与Meta分析纳入37项研究、5764例有胎盘植入谱系疾病(PAS)风险的妊娠,比较早孕期与中晚孕期超声诊断PAS的准确性。早孕期超声敏感度86%、特异度63%,中晚孕期敏感度88%、特异度92%,两者准确性相似;早孕期下段子宫血供增加敏感度最高,中晚孕期清晰带消失敏感度最高,两者子宫膀胱界面不规则特异度最高。
要点
- 早孕期超声诊断PAS的敏感度86%(95%CI 78-92%)、特异度63%(95%CI 55-70%),敏感度与中晚孕期相近但特异度较低。
- 中晚孕期超声诊断PAS的敏感度88%(95%CI 84-91%)、特异度92%(95%CI 85-96%)。
- 早孕期下段子宫血供增加敏感度最高(97%),子宫膀胱界面不规则在中晚孕期特异度最高(99%)。
核心结论
- 早孕期超声诊断PAS的准确性与中晚孕期超声检查相似;对PAS高危患者行常规早孕期超声筛查可能提高检出率并允许更早转诊至三级中心进行妊娠管理。
研究设计与样本
- 系统综述与Meta分析,检索PubMed、EMBASE和Web of Science自建库至2023年3月10日的文献;纳入评估早孕期(<14周)或中晚孕期(≥14周)超声诊断PAS准确性的队列、病例对照或横断面研究,对象为有临床危险因素的妊娠;共纳入37项研究、5764例有PAS风险的妊娠,其中1348例确诊PAS;参考标准为病理或手术检查确诊PAS。
关键影像表现/征象
- 早孕期超声征象中下段子宫血供增加敏感度最高(97%(95%CI 19-100%)),子宫膀胱界面不规则特异度最高(99%(95%CI 96-100%))。
- 中晚孕期超声征象中清晰带消失敏感度最高(80%(95%CI 72-86%)),子宫膀胱界面不规则特异度最高(99%(95%CI 97-100%))。
诊断标准与关键数值
- 早孕期超声诊断PAS:敏感度86%(95%CI 78-92%),特异度63%(95%CI 55-70%)。
- 中晚孕期超声诊断PAS:敏感度88%(95%CI 84-91%),特异度92%(95%CI 85-96%)。
- 早孕期下段子宫血供增加:敏感度97%(95%CI 19-100%);早孕期子宫膀胱界面不规则:特异度99%(95%CI 96-100%)。
- 中晚孕期清晰带消失:敏感度80%(95%CI 72-86%);中晚孕期子宫膀胱界面不规则:特异度99%(95%CI 97-100%)。
临床应用与阅片要点
- 对PAS高危患者可考虑行早孕期超声筛查,以辅助早期检出和转诊(作者结论认为可能提高检出率并允许更早转诊至三级中心)。
- 早孕期评估PAS时需注意下段子宫血供增加虽敏感度高但置信区间宽,子宫膀胱界面不规则特异度高。
- 中晚孕期评估PAS时清晰带消失敏感度较高,子宫膀胱界面不规则特异度高。
局限性
- 早孕期下段子宫血供增加的敏感度95%CI宽(19-100%)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: To assess the diagnostic accuracy of ultrasound for detecting placenta accreta spectrum (PAS) during the first trimester of pregnancy and compare it with the accuracy of second- and third-trimester ultrasound examination in pregnancies at risk for PAS.
METHODS: PubMed, EMBASE and Web of Science databases were searched to identify relevant studies published from inception until 10 March 2023. Inclusion criteria were cohort, case-control or cross-sectional studies that evaluated the accuracy of ultrasound examination performed at < 14 weeks of gestation (first trimester) or ≥ 14 weeks of gestation (second/third trimester) for the diagnosis of PAS in pregnancies with clinical risk factors. The primary outcome was the diagnostic accuracy of sonography in detecting PAS in the first trimester, compared with the accuracy of ultrasound examination in the second and third trimesters. The secondary outcome was the diagnostic accuracy of each sonographic marker individually across the trimesters of pregnancy. The reference standard was PAS confirmed at pathological or surgical examination. The potential of ultrasound and different ultrasound signs to detect PAS was assessed by computing summary estimates of sensitivity, specificity, diagnostic odds ratio and positive and negative likelihood ratios.
RESULTS: A total of 37 studies, including 5764 pregnancies at risk of PAS, with 1348 cases of confirmed PAS, were included in our analysis. The meta-analysis demonstrated that ultrasound had a sensitivity of 86% (95% CI, 78-92%) and specificity of 63% (95% CI, 55-70%) during the first trimester, and a sensitivity of 88% (95% CI, 84-91%) and specificity of 92% (95% CI, 85-96%) during the second/third trimester. Regarding sonographic markers examined in the first trimester, lower uterine hypervascularity exhibited the highest sensitivity (97% (95% CI, 19-100%)), and uterovesical interface irregularity demonstrated the highest specificity (99% (95% CI, 96-100%)). In the second/third trimester, loss of clear zone had the highest sensitivity (80% (95% CI, 72-86%)), and uterovesical interface irregularity exhibited the highest specificity (99% (95% CI, 97-100%)).
CONCLUSIONS: First-trimester ultrasound examination has similar accuracy to second- and third-trimester ultrasound examinations for the diagnosis of PAS. Routine first-trimester ultrasound screening for patients at high risk of PAS may improve detection rates and allow earlier referral to tertiary care centers for pregnancy management. © 2024 International Society of Ultrasound in Obstetrics and Gynecology.
引用
- Hessami K, Horgan R, Munoz JL, et al. Trimester-specific diagnostic accuracy of ultrasound for detection of placenta accreta spectrum: systematic review and meta-analysis. Ultrasound Obstet Gynecol. 2024. PMID: 38324675. doi:10.1002/uog.27606
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。